Comprehensive Cervical Cancer Control

Most women who die from cervical cancer, particularly in developing countries, are in the prime of their life. They may be raising children, caring for their family, and contributing to the social and economic life of their town or village. Their death is both a personal tragedy, and a sad and unnecessary loss to their family and their community. Unnecessary, because there is compelling evidence, as this Guide makes clear, that cervical cancer is one of the most preventable and treatable forms of cancer, as long as it is detected early and managed effectively. Unfortunately, the majority of women in developing countries still do not have access to cervical cancer prevention programmes. The consequence is that, often, cervical cancer is not detected until it is too late to be cured. An urgent effort is required if this situation is to be corrected. This Guide is intended to help those responsible for providing services aimed at reducing the burden posed by cervical cancer for women, communities and health systems. It focuses on the knowledge and skills needed by health care providers, at different levels of care.

This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the need for collaboration across programs, organizations and partners. This new guide updates the 2006 edition and includes the recent promising developments in technologies and strategies that can address the gaps between the needs for and availability of services for cervical cancer prevention and control. In the last few years, there has been an emergence of ground-breaking new strategies in cervical cancer prevention and control. Because such strategies require evidence-based evaluation for decision-making in clinical practice and program planning, a World Health Organization (WHO) Steering Committee and a group of invited experts met in Geneva, Switzerland, in September 2010, to ensure that the WHO's guidance on cervical cancer continues to encompass all the relevant technologies and strategies. This edition of the guide has two new chapters: Chapter 2: Essentials for cervical cancer prevention and control programs and Chapter 4: HPV vaccination. One chapter has been newly organized: Chapter 5: Screening and treatment of cervical pre-cancer. All other chapters have been thoroughly updated and edited as needed. This guide aims to assist those responsible for providing services aimed at reducing the burden of cervical cancer on women, their communities and health systems. It focuses on the knowledge, best practices and communication skills needed by health-care providers working at community and primary and secondary levels of care to offer quality services for prevention, screening, treatment and palliative care for cervical cancer: the full continuum of care. The guide is intended primarily for health-care providers in health centers and district hospitals who deal with women's health and/or adolescent's health, but it may also be of interest to community-based and tertiary-level providers. Providers and managers at the sub-national level whose responsibilities may include program planning would be interested in Chapter 2 on program essentials, which covers implementation, monitoring and evaluating, and/or supervising and training other health-care providers. National-level decision-makers will find updated evidence-based information in this guide on what works in cervical cancer prevention and control programs, which may be of use as a basis for updating their own guidelines and protocols.

In 2005, 7.6 million people died of cancer. More than 70% of those deaths occured in low and middle income countries. WHO has developed a series of six modules that provides practical advice for programme managers and policy-makers on how to advocate, plan and implement effective cancer control programmes, particularly in low and middle income countries.The WHO guide is a response to the World Health Assembly resolution on cancer prevention and control (WHA58.22), adopted in May 2005, which calls on Member States to intensify action against cancer by developing and reinforcing cancer control programmes.

Navigate the complexities of cervical cancer with the definitive guide, "Cervical Cancer: A Comprehensive Resource for Patients and Families." This book is an essential ally for those facing the diagnosis, providing clarity and support every step of the way. Understanding the BasicsBegin with a clear, concise introduction to cervical cancer, including types, prevalence, and the anatomy of the cervix. This foundational knowledge sets the stage for a deeper exploration of the condition. Risk Factors and PreventionLearn about the critical connection between HPV and cervical cancer, recognize lifestyle factors that can influence risk, and understand the life-saving potential of preventive measures like vaccinations. Early Detection and DiagnosisDiscover the importance of early symptoms and the lifesaving role of regular Pap tests and HPV screenings. Follow detailed discussions on diagnostic procedures and what to expect during the staging process. Treatment PathwaysExplore treatment options from surgery to chemotherapy, and understand the latest in targeted treatments. This book provides insight into making informed decisions that align with personal health goals. Emotional Well-beingAddress the emotional impact of a cervical cancer diagnosis with resources for coping, counseling, and finding support groups. Recognize the importance of emotional health for patients and their loved ones. Navigating Fertility and WomanhoodTackle the sensitive issues of fertility and sexuality with informed guidance. Understand the impact of cervical cancer on feminine identity and sexual health, and explore the options available. A Roadmap Through TreatmentGet practical advice for navigating the healthcare system and understanding the role of patient advocacy. This book helps demystify the journey through treatment and the importance of being an informed participant in your care. Survivorship and BeyondLook forward to life after treatment with information on managing long-term side effects and maintaining wellness. Survivorship is a key focus, providing strategies for a fulfilling life post-cancer. Understanding RecurrenceGain insights into the risks of recurrence and the strategies for ongoing monitoring and living with uncertainty, offering readers a pragmatic approach to long-term care. Advances in Cervical Cancer ResearchStay up-to-date with current research and emerging therapies. This book highlights the promise of the future of cervical cancer care and the advancements that are on the horizon. Palliative Care and DecisionsApproach palliative care and end-of-life decisions with sensitivity. This book offers compassionate advice for managing symptoms and navigating these challenging discussions. Advocacy and AwarenessUnderstand the power of education, advocacy, and global policy change in the fight against cervical cancer. This book encourages readers to become advocates for cervical health, emphasizing the importance of community and public health initiatives. "Cervical Cancer: A Comprehensive Resource for Patients and Families" is the essential guide for those looking to understand this disease, providing not just medical facts but a source of comfort and hope for patients, families, and caregivers.

Supersedes 1st edition (1995, ISBN 9241544740).

This book provides readers with a thorough review on cervical cancer, treatment guidelines and emerging therapies available for the disease. It reviews the epidemiology clinical features, diagnosis, and medical management of cervical cancer. Given the increasing need for preventive strategies, treatment optimization with collaborative and integrative work, this book improves the actual and integral knowledge in this neoplasm. Given the high prevalence of this disease in Latin America, this is an important text for clinicians in this region. This book outlines the state of the art in cervical cancer treatments and is an indispensable companion for oncologists, gynecologists, surgeons and medical students.

The WHO global health sector strategy on sexually transmitted infections, 2016–2021, endorsed by the World Health Assembly in 2016, aims to eliminate STIs as a public health threat by 2030. In 2019, WHO published estimates of new cases of chlamydia, gonorrhoea, syphilis and trichomoniasis. Recent changes in the epidemiology of STIs and progress in prevention, diagnosis and treatment of STIs and HIV have necessitated changes in approaches to STI prevention and management. To address these STIs, the most widely used approach in clinical settings is the syndromic management of STIs. In most resource-limited settings, the syndromic management flow charts are still the standard of care where laboratory diagnosis is not available or is hard to access. The objectives of these guidelines are to provide updated, evidence-informed clinical and practical recommendations on the case management of people with symptoms of STIs; and to support countries in updating their national guidelines for the case management of people with symptoms of STIs. These guidelines include the management of symptomatic infections related to urethral discharge syndrome, including persistent urethral discharge syndrome; vaginal discharge syndrome, including persistent vaginal discharge; anorectal infection; genital ulcer disease syndrome; and lower abdominal pain syndrome. These guidelines are intended for programme managers for STI prevention and control at the national level and the health-care providers at the frontline – primary, secondary and tertiary health care.

Recoge: 1. Epidemiological guidelines for quality assurance in cervical cancer screening - 2. Methods for screening and diagnosis - 3. Laboratory guidelines and quality assurance practices for cytology - 4. Techniques and quality assurance guidelines for histopathology - 5. Management of abnormal cervical cytology - 6. Key performance indicators - 7. Annexes.